When was Haemonetics founded?

Haemonetics was founded in 1971 and raised its 1st funding round 41 years after it was founded.

Where is Haemonetics located?

Haemonetics is headquartered in Braintree, United States. It is registered at 125 Summer Street, 02110 Boston, Massachusetts.

How many employees does Haemonetics have?

As of Sep 30, 2026, the latest employee count at Haemonetics is 2539.

Is Haemonetics a funded company?

Haemonetics is a funded company, having raised an undisclosed amount across 3 funding rounds to date. The company's 1st funding round was a $***** Grant (prize money) round, raised on Jan 01, 2012.

When was the latest funding round of Haemonetics?

Haemonetics' latest funding was a $***** Grant (prize money) round on Sep 15, 2021, with participation from 1 investor.

What is the annual revenue of Haemonetics?

Annual revenue of Haemonetics is more than $1B as on Mar 28, 2026

Where does Haemonetics rank among its competitors?

Haemonetics ranks 1st amongst 27 active competitors, of which 14 are funded. It stands 9th in terms of total funding among its competitors. The most recent competitor to raise funding was Immutrix Therapeutics, which secured $480K in Sep, 2025.

Who are the top competitors of Haemonetics?

Haemonetics' top competitors include VISIE, Vetex Medical and MediSieve. Among them, Immutrix Therapeutics secured the most recent funding round in September, 2025.

Haemonetics - 2026 Company Profile, Funding, Competitors & Financials

Haemonetics is a public company based in Braintree (United States), founded in 1971. It operates as a Provider of hematology products and solutions for the medical industry. Haemonetics has raised an undisclosed amount in funding. The company has 27 active competitors, including 14 funded and 3 that have exited. Its top competitors include companies like VISIE, Vetex Medical and MediSieve.

Company Details

Provider of hematology products and solutions for the medical industry. The company's products include SafeTrace a specialized transfusion management system used in the blood bank, Persona a proprietary integrated plasma collection solution built upon the NexSys PCS platform, and VASCADE arterial & venous vascular closure system to reduce complications for interventional procedures.

Website: www.haemonetics.com
Social
Email ID: *****@haemonetics.com, *****@haemonetics.com
Phone Number: +1 **********
Registered Address: 125 Summer Street, 02110 Boston, Massachusetts

Key Metrics

Founded Year

1971

Location

Braintree, United States

Stage

Public

Latest Funding Round

Grant (prize money), Sep 15, 2021, $*****

Investors

Blum Capital & 2 more

Ranked

1^st among 27 active competitors

Annual Revenue

$1B+ as on Mar 28, 2026

Employee Count

2,539 as on Sep 30, 2026

Investment & Acquisitions

Vivasure Medical & 9 more

Similar Companies

VISIE & 30 more

Exit Details

Public

View Haemonetics' full profile

Haemonetics is associated with 6 legal entities given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
U.T.A.H. - KU, spol. s r.o. CIN: 47909161 , Czech Republic, Active	Feb 04, 1993	-	-
Haemonetics CZ, spol. s r.o. CIN: 25555952 , Czech Republic, Active	Mar 02, 1999	-	-
HAEMONETICS CORP CIN: 313143 , United States, Active	Feb 22, 1990	$1B+ (As on Mar 28, 2026)	-	-
HAEMONETICS HEALTHCARE INDIA PRIVATE LIMITED CIN: U33100KA2013PTC068103 , India, Active	Mar 06, 2013	0 - ₹10 Cr (As on Mar 31, 2025)	-
Haemonetics Corporation CIN: 04-2882273 , United States, Active	Dec 31, 1970	-	3034 (As on Apr 30, 2023)	-
HAEMONETICS PUERTO RICO, LLC CIN: 660785754 , United States, Active	Dec 31, 1999	-	18 (As on Dec 31, 2024)	-

Haemonetics got listed on May 24, 1991.

Click here to take a look at Haemonetics's IPO in detail

Haemonetics has raised funding over 3 rounds. Its first funding round was on Jan 01, 2012. Its latest funding round was a Grant (prize money) round on Sep 15, 2021 for $*****. 1 investor participated in its latest round. Haemonetics has 3 institutional investors.

Here is the list of recent funding rounds of Haemonetics:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Sep 15, 2021	8788288	Grant (prize money)	5516085	4343855	3333951	4336126
Mar 02, 2021	6752198	Post IPO	6988675	4151650	1818629	9488909
Jan 01, 2012	5983142	Grant (prize money)	3067807	1992161	5557369	HHS

Access funding benchmarks and valuations. Sign up today!

View details of Haemonetics's funding rounds and investors

Haemonetics' employee count trend

Haemonetics has 2,539 employees as of Sep 26. Here is Haemonetics's employee count trend over the years:

Uncover Haemonetics' growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Haemonetics include VISIE, Vetex Medical and MediSieve. Here is the list of Top 10 competitors of Haemonetics, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Haemonetics 1971, Braintree (United States), Public	Provider of hematology products and solutions for the medical industry	-	Blum Capital, Partners For Growth & 1 others	62/100
2nd	VISIE 2017, Austin (United States), Series A	Provider of 3D intraoperative imaging technology for orthopedic, neuro, and spine surgery	$12.7M	Capital Factory, Flat Rock Global & 7 others	54/100
3rd	Vetex Medical 2016, Galway (Ireland), Acquired	Developer of catheter for clot management in veins	-	EIC Fund, European Innovation Council & 1 others	41/100
4th	MediSieve 2014, London (United Kingdom), Series A	Developer of magnetic therapy to treat blood borne diseases	$4.18M	24 Haymarket, EIC Fund & 23 others	40/100
5th	Sisu Global Health 2014, Baltimore (United States), Seed	Provider of intraoperative autotransfusion device	$3.1M	Dreamit, Michbelles & 23 others	39/100
6th	Gausssurgical.com 2011, Los Altos (United States), Acqui-Hired	AI-powered medical device for perioperative care	$60.2M	Allumia Ventures, Promus Ventures & 13 others	38/100
7th	Haermonics 2015, Amsterdam (Netherlands), Series A	A drainage and flushing system for postoperative pericardial flushing	$4.41M	Invest-NL, BOM & 3 others	37/100
8th	Plasmology4 2010, Scottsdale (United States), Seed	Cold plasma treatment	$6.39M	-	35/100
9th	Immutrix Therapeutics 2009, Rapid City (United States), Series A	Innovating blood filtration technologies for critical care and unmet medical needs	$14M	-	35/100
10th	Gate Science 2020, Boston (United States), Seed	Developer of a multi-modal device for post-surgery pain	$150K	-	34/100

Get insights and benchmarks for competitors of 2M+ companies! Sign up today!

Looking for more details on Haemonetics's competitors? Click here to see the top ones

Haemonetics has made 1 investments in companies including Vivasure Medical. Haemonetics has also acquired 9 companies including Vivasure Medical and Attune Medical.

Here is the list of investments & acquisitions:

Filter this list

Date of Investment/Acquisition	Type	Company Name	Founded Year	Location
Jan 09, 2026	Acquisition	Vivasure Medical	2009	Galway (Ireland)
Mar 05, 2024	Acquisition	Attune Medical	2009	Chicago (United States)
Oct 10, 2023	Acquisition	OpSens	2003	Quebec City (Canada)